Kornitzer Capital Management Inc. KS Increases Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Kornitzer Capital Management Inc. KS raised its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 26.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 389,160 shares of the company's stock after purchasing an additional 81,155 shares during the period. Kornitzer Capital Management Inc. KS owned 1.51% of Establishment Labs worth $10,075,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Legal & General Group Plc raised its position in Establishment Labs by 2.3% during the 4th quarter. Legal & General Group Plc now owns 6,965 shares of the company's stock valued at $457,000 after purchasing an additional 157 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Establishment Labs by 0.8% during the 1st quarter. Geode Capital Management LLC now owns 22,736 shares of the company's stock worth $1,540,000 after acquiring an additional 176 shares during the period. California State Teachers Retirement System grew its holdings in shares of Establishment Labs by 1.3% during the 1st quarter. California State Teachers Retirement System now owns 16,285 shares of the company's stock worth $1,097,000 after acquiring an additional 204 shares during the period. Walleye Capital LLC grew its holdings in shares of Establishment Labs by 3.9% during the 1st quarter. Walleye Capital LLC now owns 6,119 shares of the company's stock worth $412,000 after acquiring an additional 228 shares during the period. Finally, BNP Paribas Arbitrage SA grew its holdings in shares of Establishment Labs by 39.9% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 842 shares of the company's stock worth $46,000 after acquiring an additional 240 shares during the period. Institutional investors own 72.91% of the company's stock.

Establishment Labs Stock Down 9.9 %

Shares of Establishment Labs stock traded down $5.19 during midday trading on Friday, hitting $47.38. The company had a trading volume of 427,182 shares, compared to its average volume of 319,381. The company has a debt-to-equity ratio of 10.26, a quick ratio of 1.67 and a current ratio of 3.06. The stock has a market capitalization of $1.30 billion, a P/E ratio of -15.59 and a beta of 1.24. The company has a 50 day moving average of $47.12 and a 200 day moving average of $36.32. Establishment Labs Holdings Inc. has a 52-week low of $16.96 and a 52-week high of $77.55.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its earnings results on Wednesday, February 28th. The company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.95) by $0.16. Establishment Labs had a negative return on equity of 357.81% and a negative net margin of 47.53%. The business had revenue of $31.60 million for the quarter, compared to the consensus estimate of $31.44 million. During the same period last year, the business posted ($0.55) EPS. The company's revenue was down 27.9% compared to the same quarter last year. On average, equities analysts predict that Establishment Labs Holdings Inc. will post -1.58 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Mizuho upped their target price on Establishment Labs from $50.00 to $65.00 and gave the stock a "buy" rating in a report on Monday, April 1st. JPMorgan Chase & Co. upped their target price on Establishment Labs from $46.00 to $53.00 and gave the stock an "overweight" rating in a report on Thursday, February 29th. Citigroup upped their target price on Establishment Labs from $49.00 to $60.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Finally, Stephens restated an "overweight" rating and issued a $47.00 price target on shares of Establishment Labs in a research note on Thursday, January 11th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, Establishment Labs currently has a consensus rating of "Buy" and an average price target of $55.00.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.